Synthesis and antimicrobial activity of aminoglycoside-conjugated silica nanoparticles against clinical and resistant bacteria

Shrish Agnihotri, Rajiv Pathak, Diksha Jha, Indrajit Roy, Hemant K. Gautam, Ashwani K. Sharma, Pradeep Kumar

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

Functionalization of silica nanoparticles with different cationic moieties makes them suitable for being an effective antimicrobial agent against various clinical pathogenic microbes. Here, we report the synthesis, characterization and evaluation of aminoglycoside-conjugated silica nanoparticles [S-X NPs, where X = gentamicin (G), neomycin (N) or kanamycin (K)] for their antimicrobial activity against clinical pathogens and kanamycin-resistant E. coli. These functionalized silica nanoparticles exhibited enhanced broad-spectrum antimicrobial activity against clinical Gram-positive and Gram-negative bacteria as well as kanamycin-resistant E. coli strain with minimal cytotoxicity. The results show the potential of these conjugates to combat drug resistance.

Original languageEnglish (US)
Pages (from-to)6746-6755
Number of pages10
JournalNew Journal of Chemistry
Volume39
Issue number9
DOIs
StatePublished - Apr 8 2015
Externally publishedYes

ASJC Scopus subject areas

  • Catalysis
  • Chemistry(all)
  • Materials Chemistry

Fingerprint

Dive into the research topics of 'Synthesis and antimicrobial activity of aminoglycoside-conjugated silica nanoparticles against clinical and resistant bacteria'. Together they form a unique fingerprint.

Cite this